Variant report
Variant | esv3313791 |
---|---|
Chromosome Location | chr16:77217151-77222249 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:26)
- CpG islands (count:61)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:26 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr16:77217151-77217377 | A549 | lung: | n/a | n/a |
2 | CEBPB | chr16:77216988-77217453 | A549 | lung: | n/a | n/a |
3 | CTCF | chr16:77221340-77221490 | GM12878 | blood: | n/a | n/a |
4 | FOS | chr16:77217006-77217718 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr16:77216954-77217722 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOS | chr16:77217023-77217788 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | FOS | chr16:77216953-77217800 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | FOXA1 | chr16:77222011-77222438 | HepG2 | liver: | n/a | chr16:77222262-77222274 |
9 | FOXA1 | chr16:77222039-77222541 | HepG2 | liver: | n/a | chr16:77222262-77222274 |
10 | JUN | chr16:77217081-77217315 | HepG2 | liver: | n/a | n/a |
11 | JUND | chr16:77217042-77217366 | HepG2 | liver: | n/a | chr16:77217197-77217208 |
12 | KAP1 | chr16:77217767-77218404 | K562 | blood: | n/a | n/a |
13 | MYC | chr16:77216989-77217342 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | MYC | chr16:77217023-77217373 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | POLR2A | chr16:77221433-77221482 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | POLR2A | chr16:77217824-77217891 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | POLR2A | chr16:77219451-77219651 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | RFX5 | chr16:77220859-77221111 | K562 | blood: | n/a | n/a |
19 | STAT3 | chr16:77217127-77217337 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | STAT3 | chr16:77217130-77217336 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | STAT3 | chr16:77217088-77217690 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | STAT3 | chr16:77217022-77217410 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | STAT3 | chr16:77217105-77217362 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | TCF7L2 | chr16:77217081-77217281 | PANC-1 | pancreas: | n/a | n/a |
25 | UBTF | chr16:77218014-77218046 | K562 | blood: | n/a | n/a |
26 | ZNF274 | chr16:77217141-77217288 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:77221668-77221718 | T-47D | breast: | n/a |
2 | chr16:77221668-77221718 | U87 | brain: | n/a |
3 | chr16:77221668-77221718 | HRPEpiC | eye: | n/a |
4 | chr16:77221668-77221718 | HEK293 | kidney: | embryo |
5 | chr16:77221668-77221718 | Jurkat | blood: | n/a |
6 | chr16:77221668-77221718 | NB4 | blood: | n/a |
7 | chr16:77221668-77221718 | HUVEC | blood vessel: | n/a |
8 | chr16:77221668-77221718 | ECC-1 | luminal epithelium: | n/a |
9 | chr16:77221668-77221718 | HRCEpiC | kidney: | n/a |
10 | chr16:77221668-77221718 | HepG2 | liver: | n/a |
11 | chr16:77221668-77221718 | PFSK-1 | brain: | n/a |
12 | chr16:77221668-77221718 | HMEC | breast: | n/a |
13 | chr16:77221668-77221718 | Caco-2 | colon: | n/a |
14 | chr16:77221668-77221718 | HAEpiC | amniotic membrane: | n/a |
15 | chr16:77221668-77221718 | BJ | skin: | n/a |
16 | chr16:77221668-77221718 | SAEC | small airway: | n/a |
17 | chr16:77221668-77221718 | AG09309 | skin: | n/a |
18 | chr16:77221668-77221718 | AG09319 | gingival: | n/a |
19 | chr16:77221668-77221718 | GM12891 | blood: | n/a |
20 | chr16:77221668-77221718 | HRE | kidney: | n/a |
21 | chr16:77221668-77221718 | HL-60 | blood: | n/a |
22 | chr16:77221668-77221718 | SK-N-SH_RA | brain: | n/a |
23 | chr16:77221668-77221718 | NHDF-neo | bronchial: | n/a |
24 | chr16:77221668-77221718 | GM12892 | blood: | n/a |
25 | chr16:77221668-77221718 | GM06990 | blood: | n/a |
26 | chr16:77221668-77221718 | A549 | lung: | n/a |
27 | chr16:77221668-77221718 | CMK | blood: | n/a |
28 | chr16:77221668-77221718 | AG10803 | skin: | n/a |
29 | chr16:77221668-77221718 | ProgFib | skin: | n/a |
30 | chr16:77221668-77221718 | Hela-S3 | cervix: | n/a |
31 | chr16:77221668-77221718 | MCF-7 | breast: | n/a |
32 | chr16:77221668-77221718 | HEEpiC | esophagus: | n/a |
33 | chr16:77221668-77221718 | PANC-1 | pancreas: | n/a |
34 | chr16:77221668-77221718 | HNPCEpiC | eye: | n/a |
35 | chr16:77221668-77221718 | HPAEpiC | pulmonary alveolar: | n/a |
36 | chr16:77221668-77221718 | SKMC | muscle: | n/a |
37 | chr16:77221668-77221718 | HCPEpiC | choroid plexus: | n/a |
38 | chr16:77221668-77221718 | ovcar-3 | ovarian: | n/a |
39 | chr16:77221668-77221718 | BE2_C | brain: | n/a |
40 | chr16:77221668-77221718 | H1-hESC | embryonic stem cell: | embryo |
41 | chr16:77221668-77221718 | K562 | blood: | n/a |
42 | chr16:77221668-77221718 | NHBE | bronchial: | n/a |
43 | chr16:77221668-77221718 | AoSMC | blood vessel: | n/a |
44 | chr16:77221668-77221718 | GM12878 | blood: | n/a |
45 | chr16:77221668-77221718 | MCF10A-Er-Src | breast: | n/a |
46 | chr16:77221668-77221718 | HCT-116 | colon: | n/a |
47 | chr16:77221668-77221718 | HCF | heart: | n/a |
48 | chr16:77221668-77221718 | LNCaP | prostate: | n/a |
49 | chr16:77221668-77221718 | NT2-D1 | testis: | n/a |
50 | chr16:77221668-77221718 | PrEC | prostate: | n/a |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:77206067..77208430-chr16:77215088..77217473,2 | MCF-7 | breast: | |
2 | chr16:77217047..77218852-chr16:77220836..77222789,2 | K562 | blood: | |
3 | chr16:77217047..77218852-chr16:77220836..77222789,2 | K562 | blood: | |
4 | chr16:77216325..77218359-chr16:77222918..77225475,2 | MCF-7 | breast: | |
5 | chr16:77219105..77221826-chr16:77222885..77224694,2 | MCF-7 | breast: | |
6 | chr16:77219312..77221017-chr16:77223275..77224910,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
MON1B | TF binding region |
MON1B | CpG island |
ENSG00000103111 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553305200 | chr16:77217183-77217184 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs576577578 | chr16:77217209-77217210 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs9939130 | chr16:77217210-77217211 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs148716269 | chr16:77217267-77217268 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs576165836 | chr16:77217268-77217269 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs541632996 | chr16:77217269-77217270 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs9939212 | chr16:77217270-77217271 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs572199123 | chr16:77217296-77217297 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs564032577 | chr16:77217305-77217306 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs529729541 | chr16:77217321-77217322 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs540673980 | chr16:77217335-77217336 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs9930201 | chr16:77217376-77217377 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs142457676 | chr16:77217388-77217389 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs151314802 | chr16:77217403-77217404 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs181823338 | chr16:77217410-77217411 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs572872234 | chr16:77217483-77217484 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs566303671 | chr16:77217534-77217535 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs528191102 | chr16:77217539-77217540 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs377388152 | chr16:77217558-77217559 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs185174502 | chr16:77217571-77217572 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs188141349 | chr16:77217578-77217579 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs548342410 | chr16:77217579-77217580 | Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs552415707 | chr16:77217614-77217615 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs562941225 | chr16:77217615-77217616 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs369520222 | chr16:77217616-77217617 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs534218705 | chr16:77217690-77217691 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs535380696 | chr16:77217696-77217697 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs140558010 | chr16:77217705-77217706 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs9923489 | chr16:77217734-77217735 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs539177248 | chr16:77217744-77217745 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs555864540 | chr16:77217836-77217837 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs576011582 | chr16:77217848-77217849 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs145764517 | chr16:77217849-77217850 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs555266315 | chr16:77217859-77217860 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs181323965 | chr16:77217873-77217874 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs186187975 | chr16:77217892-77217893 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs560499872 | chr16:77217909-77217910 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs146603262 | chr16:77217939-77217940 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs546184302 | chr16:77217962-77217963 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs570711692 | chr16:77217991-77217992 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs563009705 | chr16:77218064-77218065 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs531667624 | chr16:77218086-77218087 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs548811752 | chr16:77218087-77218088 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs191880724 | chr16:77218136-77218137 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs528015546 | chr16:77218162-77218163 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs183305399 | chr16:77218174-77218175 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs570783106 | chr16:77218217-77218218 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs532782523 | chr16:77218226-77218227 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs59374564 | chr16:77218284-77218285 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs572744725 | chr16:77218289-77218290 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 19156837 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Breast cancer | 20409316 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Lung cancer | 24585490 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20581869 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Melanoma | 17363583 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:77216800-77217200 | Enhancers | NHEK | skin |
2 | chr16:77217200-77217600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr16:77217200-77217600 | Flanking Active TSS | A549 | lung |
4 | chr16:77217600-77218000 | Enhancers | A549 | lung |
5 | chr16:77222000-77223800 | Enhancers | HepG2 | liver |